People taking GLP-1 drugs can decrease fat mass while minimizing muscle loss with a few key strategies that include proper ...

Pfizer said it will stop development of an oral weight-loss pill after a participant taking the drug in a clinical trial ...

A new Canadian guideline urges lifestyle interventions for obese children but also says today's new drugs might help kids ...

Meghan Trainor's use of the hotly-debated diabetes drug Mounjaro to shed a few pounds has subsequently become somewhat of a ...

The list of “biohacks” is extensive and includes extreme diets, supplement use, juicing, red light therapy, cold exposure in ...

FROM sulphur burps to diarrhoea, we’re all familiar with the brutal side effects of fat jabs – but have you heard of ‘Ozempic ...

Pooled annual prevalence of GLP-1 RA use was 0.1 percent from 2018 to 2021 and increased to 0.4 percent by 2022.

Combination therapy with GLP-1 RAs and thiazolidinediones is associated with a reduced risk for mortality in patients with T2D, a study finds.

The University will not surrender its independence or relinquish its constitutional rights. Neither Harvard nor any other ...

From STAT’s Matthew Herper: Pfizer said this morning that it would stop development of danuglipron, its experimental oral GLP ...